Ignite Creation Date:
2024-05-06 @ 3:38 PM
Last Modification Date:
2024-10-26 @ 1:54 PM
Study NCT ID:
NCT04708340
Status:
UNKNOWN
Last Update Posted:
2022-03-15
First Post:
2021-01-04
Brief Title:
Tolerability and Efficacy of RJX in Patients With COVID-19
Sponsor:
Reven Pharmaceuticals Inc
Organization:
Reven Pharmaceuticals Inc
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-03-25
Start Date Type:
ACTUAL
Primary Completion Date:
2022-10
Primary Completion Date Type:
ESTIMATED
Completion Date:
2023-02
Completion Date Type:
ESTIMATED
First Submit Date:
2021-01-04
First Submit QC Date:
January 12 2021
Study First Post Date:
2021-01-13
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-03-14
Last Update Post Date:
2022-03-15
Last Update Post Date Type:
ACTUAL